Yuxin Cui

1.7k total citations
61 papers, 1.3k citations indexed

About

Yuxin Cui is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Yuxin Cui has authored 61 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Molecular Biology, 15 papers in Oncology and 15 papers in Cancer Research. Recurrent topics in Yuxin Cui's work include MicroRNA in disease regulation (5 papers), Cancer-related gene regulation (5 papers) and Immunotherapy and Immune Responses (4 papers). Yuxin Cui is often cited by papers focused on MicroRNA in disease regulation (5 papers), Cancer-related gene regulation (5 papers) and Immunotherapy and Immune Responses (4 papers). Yuxin Cui collaborates with scholars based in China, United Kingdom and United States. Yuxin Cui's co-authors include Wen G. Jiang, Valentina Flamini, Daniela Cesselli, Orazio Fortunato, Costanza Emanueli, Federica Riu, Paolo Madeddu, Miriam Gubernator, Elisa Avolio and Rajesh Katare and has published in prestigious journals such as Blood, PLoS ONE and Circulation Research.

In The Last Decade

Yuxin Cui

59 papers receiving 1.3k citations

Peers

Countries citing papers authored by Yuxin Cui

Since Specialization

Citations

This map shows the geographic impact of Yuxin Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuxin Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuxin Cui more than expected).

Fields of papers citing papers by Yuxin Cui

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuxin Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuxin Cui. The network helps show where Yuxin Cui may publish in the future.

Co-authorship network of co-authors of Yuxin Cui

This figure shows the co-authorship network connecting the top 25 collaborators of Yuxin Cui. A scholar is included among the top collaborators of Yuxin Cui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuxin Cui. Yuxin Cui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Pancreas Transplantation in Type 2 Diabetics is Associated with Lower Rates of Graft Rejection and Graft Loss Compared with Type 1 Diabetics 2025 ·American Journal of Transplantation ·(unknown), (unknown), T O Lim, (unknown), (unknown), (unknown), Yuxin Cui, (unknown), Tsuyoshi Todo, (unknown), Justin Steggerda, Sheik Wisel, Todd V. Brennan	0
2	Patient-derived organoids and mini-PDX for predicting METN375S-mutated lung cancer patient clinical therapeutic response 2024 ·Heliyon ·Ming Jiang, Rongfu Tu, Yiwen Pan, Yuxin Cui, Xin Qi, Hongyu Qin, Lijuan Liu, Xiaorui Wang, Ying Xue, Yao Xu, (unknown), Chengsheng Zhang, (unknown)	1
3	A cohort study of circulating progenitor cells after ST-segment elevation and non-ST segment elevation myocardial infarction in non-diabetic and diabetic patients 2022 ·Frontiers in Cardiovascular Medicine ·Andreas Baumbach, Yuxin Cui, Rebecca Evans, Lucy Culliford, Tom Johnson, Chris Rogers, Barnaby C Reeves, Chiara Bucciarelli‐Ducci, Jessica Harris, Mark F. Hamilton, Paolo Madeddu	0
4	DeepSeqPanII: An Interpretable Recurrent Neural Network Model With Attention Mechanism for Peptide-HLA Class II Binding Prediction 2021 ·IEEE/ACM Transactions on Computational Biology and Bioinformatics ·Zhonghao Liu, Jing Jin, Yuxin Cui, Zheng Xiong, Alireza Nasiri, Yong Zhao, Jianjun Hu	26
5	Lead DEAD/H box helicase biomarkers with the therapeutic potential identified by integrated bioinformatic approaches in lung cancer 2020 ·Computational and Structural Biotechnology Journal ·Yuxin Cui, (unknown), (unknown), (unknown), Jane Lane, Fiona Ruge, Wen G. Jiang	12
6	Calcium-Binding Protein S100P Promotes Tumor Progression but Enhances Chemosensitivity in Breast Cancer 2020 ·Frontiers in Oncology ·(unknown), Yuxin Cui, Suxia Wang, Lei Jiang, (unknown), Shiguang Zhu, (unknown), Jane Lane, Fiona Ruge, Wen G. Jiang, Guangdong Qiao	24
7	EphB2 represents an independent prognostic marker in patients with gastric cancer and promotes tumour cell aggressiveness 2020 ·Journal of Cancer ·Jie Yin, (unknown), Lin Ye, (unknown), Liting Li, (unknown), Guangyong Chen, Jiafu Ji, Zhongtao Zhang, Wen G. Jiang, Yuxin Cui	14
8	OPN promotes the aggressiveness of non-small-cell lung cancer cells through the activation of the RON tyrosine kinase 2019 ·Scientific Reports ·Chengcheng Hao, Yuxin Cui, Siyuan Chang, Jing Huang, (unknown), Mu Hu, Xiuyi Zhi, Wenbin Li, Lijian Zhang, Shan Cheng, Wen G. Jiang	17
9	Human osteopontin: Potential clinical applications in cancer (Review) 2017 ·International Journal of Molecular Medicine ·Chengcheng Hao, Yuxin Cui, (unknown), Wenbin Li, Shan Cheng, Wen G. Jiang	69
10	Therapeutic Role of MiR-140-5p for the Treatment of Non-small Cell Lung Cancer 2017 ·Anticancer Research ·Valentina Flamini, Wen G. Jiang, Yuxin Cui	38
11	OPN-a Splicing Variant Expression in Non-small Cell Lung Cancer and its Effects on the Bone Metastatic Abilities of Lung Cancer Cells In Vitro 2017 ·Anticancer Research ·Chengcheng Hao, Yuxin Cui, Mu Hu, Xiuyi Zhi, Lijian Zhang, Wenbin Li, Wei Wu, Shan Cheng, Wen G. Jiang	15
12	Overexpression of EPHB4 Is Associated with Poor Survival of Patients with Gastric Cancer 2017 ·Anticancer Research ·Jie Yin, Yuxin Cui, Liting Li, Jiafu Ji, Wen G. Jiang	9
13	Significance and therapeutic implications of endothelial progenitor cells in angiogenic-mediated tumour metastasis 2016 ·Critical Reviews in Oncology/Hematology ·Valentina Flamini, Wen G. Jiang, Jane Lane, Yuxin Cui	17
14	Stepwise Optimization of the Procedure for Assessment of Circulating Progenitor Cells in Patients with Myocardial Infarction 2012 ·PLoS ONE ·Yuxin Cui, Tom Johnson, Andreas Baumbach, Barnaby C Reeves, Chris Rogers, Gianni D. Angelini, (unknown), Paolo Madeddu	4
15	A New Methodological Sequence to Expand and Transdifferentiate Human Umbilical Cord Blood Derived CD133+ Cells into a Cardiomyocyte-like Phenotype 2011 ·Stem Cell Reviews and Reports ·Yuxin Cui, Wael Kafienah, M.Saadeh Suleiman, Raimondo Ascione	7
16	Synthesis and biological evaluation of novel C5 halogen-functionalized S-DABO as potent HIV-1 non-nucleoside reverse transcriptase inhibitors 2010 ·Bioorganic & Medicinal Chemistry ·Hua Qin, Chang Liu, Ying Guo, Ruiping Wang, (unknown), Liying Ma, Zhili Zhang, Xiaowei Wang, Yuxin Cui, Junyi Liu	20
17	Chiral gossypol derivatives: Evaluation of their anticancer activity and molecular modeling 2009 ·European Journal of Medicinal Chemistry ·(unknown), Haixia Jiang, (unknown), (unknown), Fan Wang, Yuxin Cui, Biao Jiang	33
18	ECRG2 inhibits cancer cell migration, invasion and metastasis through the down-regulation of uPA/plasmin activity 2007 ·Carcinogenesis ·Ge Huang, Zhanying Hu, Mingyang Li, Yuxin Cui, Yanping Li, Liping Guo, Wei Jiang, (unknown)	29
19	Structure–activity relationships of novel endomorphin-2 analogues with N–O turns induced by α-aminoxy acids 2005 ·Bioorganic & Medicinal Chemistry Letters ·Jie Wei, Xuan Shao, (unknown), Beibei Zhu, Yuxin Cui, Yanfeng Gao, Rui Wang	10
20	Molecular phylogeny of serow based on mitochondrial cytochrome b gene sequence 2001 ·Yuxin Cui, Xiaoming Wang, (unknown)	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact